Zenicor posted record Q1 revenue and returned to profitability, driven by UK expansion and strong demand for arrhythmia diagnostics. Cash flow remains a challenge, but ongoing contracts and studies support long-term growth prospects.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.